PRKDC and cancer: Absence of IRF3 disrupted type I IFN responses in T98G cells (Figs 2F and EV2H), supporting that DNA‐PK‐dependent, STING‐independent, type I IFN responses require IRF3 in cancer cells presenting undetectable cGAS levels.